Locations
coventry, uk
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2019
Nano Syrinx is a discovery stage synthetic biology company focused on creating a next-generation platform technology for the targeted intracellular delivery of biological molecules. The company aims to address the challenges faced by biologic drugs, such as antibodies and peptides, which struggle to effectively traverse the body. By leveraging over a decade of fundamental research, Nano Syrinx is developing a novel system based on naturally occurring 'nanosyringes' that can encapsulate and deliver therapeutic payloads directly to the cytosol in a targeted manner. This innovative approach positions Nano Syrinx to revolutionize the administration of medicines on a nanoscopic scale, unlocking new therapeutic opportunities that are currently difficult to access.
Something looks off?